Author: Zhichao Feng; Jennifer Li; Shanhu Yao; Qizhi Yu; Wenming Zhou; Xiaowen Mao; Huiling Li; Wendi Kang; Xin Ouyang; Ji Mei; Qiuhua Zeng; Jincai Liu; Xiaoqian Ma; Pengfei Rong; Wei Wang
Title: The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis Document date: 2020_4_10
ID: k65501xp_13
Snippet: We extracted the demographic, exposure history, comorbidities, clinical symptoms, and laboratory data on admission from electronic medical records. Medication history among individuals with hypertension was recorded, including ACEI/ARB, calcium-antagonists, β -blocker, and diuretic agents. All laboratory tests were performed according to the clinical care needs of the patient during hospitalization, including a complete blood count, assessment o.....
Document: We extracted the demographic, exposure history, comorbidities, clinical symptoms, and laboratory data on admission from electronic medical records. Medication history among individuals with hypertension was recorded, including ACEI/ARB, calcium-antagonists, β -blocker, and diuretic agents. All laboratory tests were performed according to the clinical care needs of the patient during hospitalization, including a complete blood count, assessment of liver and renal function, coagulation testing, and measures of electrolytes, creatine kinase, lactate dehydrogenase, procalcitonin, and C-reactive protein. The use of antiviral therapy (arbidol, lopinavir/ritonavir, and interferon α ) and chloroquine were obtained from the medication administration record. The severity degree of COVID-19 at the time of admission is defined as follows: (1) mild type, with fever or respiratory tract symptoms but without radiological pneumonia. (2) moderate type, with fever, respiratory tract symptoms, and radiological evidence of pneumonia. (3) severe type, with . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- admission time and blood count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- admission time and care need: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- admission time and clinical symptom: 1, 2, 3, 4, 5, 6
- admission time and complete blood count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- admission time and creatine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- admission time and electronic medical record: 1, 2, 3, 4, 5
- admission time and exposure history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral therapy and blood count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral therapy and calcium antagonist: 1
- antiviral therapy and care need: 1, 2, 3, 4, 5, 6, 7
- antiviral therapy and cc NC ND International license: 1, 2, 3, 4, 5, 6
- antiviral therapy and clinical symptom: 1
- antiviral therapy and complete blood count: 1, 2, 3
- antiviral therapy and creatine kinase: 1, 2, 3, 4, 5
- blood count and clinical symptom: 1, 2, 3, 4
- blood count and coagulation testing: 1, 2
- blood count and complete blood count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- blood count and creatine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- blood count and electronic medical record: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date